» Articles » PMID: 37863612

Artificial Intelligence in Clinical Workflow Processes in Vascular Surgery and Beyond

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

In the past decade, artificial intelligence (AI)-based applications have exploded in health care. In cardiovascular disease, and vascular surgery specifically, AI tools such as machine learning, natural language processing, and deep neural networks have been applied to automatically detect underdiagnosed diseases, such as peripheral artery disease, abdominal aortic aneurysms, and atherosclerotic cardiovascular disease. In addition to disease detection and risk stratification, AI has been used to identify guideline-concordant statin therapy use and reasons for nonuse, which has important implications for population-based cardiovascular disease health. Although many studies highlight the potential applications of AI, few address true clinical workflow implementation of available AI-based tools. Specific examples, such as determination of optimal statin treatment based on individual patient risk factors and enhancement of intraoperative fluoroscopy and ultrasound imaging, demonstrate the potential promise of AI integration into clinical workflow. Many challenges to AI implementation in health care remain, including data interoperability, model bias and generalizability, prospective evaluation, privacy and security, and regulation. Multidisciplinary and multi-institutional collaboration, as well as adopting a framework for integration, will be critical for the successful implementation of AI tools into clinical practice.

Citing Articles

Differentiating Cystic Lesions in the Sellar Region of the Brain Using Artificial Intelligence and Machine Learning for Early Diagnosis: A Prospective Review of the Novel Diagnostic Modalities.

Patel K, Sanghvi H, Gill G, Agarwal O, Pandya A, Agarwal A Cureus. 2025; 16(12):e75476.

PMID: 39791061 PMC: 11717160. DOI: 10.7759/cureus.75476.


Humans use tools: From handcrafted tools to artificial intelligence.

Garza-Herrera R J Vasc Surg Venous Lymphat Disord. 2023; 12(2):101705.

PMID: 37956905 PMC: 11523427. DOI: 10.1016/j.jvsv.2023.101705.

References
1.
Flores A, Demsas F, Leeper N, Ross E . Leveraging Machine Learning and Artificial Intelligence to Improve Peripheral Artery Disease Detection, Treatment, and Outcomes. Circ Res. 2021; 128(12):1833-1850. PMC: 8285054. DOI: 10.1161/CIRCRESAHA.121.318224. View

2.
Maurel B, Martin-Gonzalez T, Chong D, Irwin A, Guimbretiere G, Davis M . A prospective observational trial of fusion imaging in infrarenal aneurysms. J Vasc Surg. 2018; 68(6):1706-1713.e1. DOI: 10.1016/j.jvs.2018.04.015. View

3.
Schmuelling L, Franzeck F, Nickel C, Mansella G, Bingisser R, Schmidt N . Deep learning-based automated detection of pulmonary embolism on CT pulmonary angiograms: No significant effects on report communication times and patient turnaround in the emergency department nine months after technical implementation. Eur J Radiol. 2021; 141:109816. DOI: 10.1016/j.ejrad.2021.109816. View

4.
Gobbel G, Matheny M, Reeves R, Akeroyd J, Turchin A, Ballantyne C . Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease. Am J Prev Cardiol. 2021; 9:100300. PMC: 8671496. DOI: 10.1016/j.ajpc.2021.100300. View

5.
Sarraju A, Ward A, Li J, Valencia A, Palaniappan L, Scheinker D . Personalizing cholesterol treatment recommendations for primary cardiovascular disease prevention. Sci Rep. 2022; 12(1):23. PMC: 8742083. DOI: 10.1038/s41598-021-03796-6. View